Daré Bioscience, Inc. (DARE)
NASDAQ·Healthcare·Biotechnology
$1.36
+6.25%
Mkt Cap $14.57M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+782.4%
Consensus $12.00 vs current $1.36
NASDAQ·Healthcare·Biotechnology
$1.36
+6.25%
Mkt Cap $14.57M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+782.4%
Consensus $12.00 vs current $1.36